All In Biotech

Drug Trial Radar · NCT05541276

MELAtonin for Prevention of Postoperative Agitation and Emergence Delirium in Children

MELAtonin for Prevention of Postoperative Agitation and Emergence Delirium in Children. The MELA-PAED Trial: a Randomized, Double-blind, Placebo-controlled Trial.

Last checked: Nov 20, 2026Latest source record: Aug 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 676 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

676

Planned (sponsor's estimate)

Start

Jan 21, 2025

Primary completion

Mar 1, 2027

Study completion Apr 1, 2027

Sponsor

Lead sponsor
Arash AfshariAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Sygehus Lillebaelt; University of Copenhagen; Copenhagen Trial Unit, Center for Clinical Intervention Research
First posted
Sep 15, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Prevention
FDA-regulated drug
No
Who can join
All sexes, from 1 year, up to 6 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Postoperative agitation and emergence delirium describe a spectrum of symptoms of early postoperative negative behavior, in which the child experiences a variety of behavioral disturbances including crying, thrashing, and disorientation during early awakening from anaesthesia. The symptoms are common with a reported incidence of approximately 25%. Some clinical trials have studied the effect of prophylactic oral melatonin for reducing the risk of emergence agitation in children, some finding a considerable dose-response effect. Melatonin has a low bio-availability of approximately 15 %. The safety of exogenous melatonin for pediatric patients has been studied with no apparent serious adverse effects, even at repeated short-term use of high doses of intravenous melatonin. The aim of this clinical trial is to investigate the prophylactic effects and safety of intravenous melatonin administered intraoperatively for prevention of postopreative agitation and emergence delirium in children after an elective surgical procedure. The study is designed as a randomised, double-blind, placebo-controlled clinical trial.

Conditions

  • Emergence Delirium

Interventions

  • MelatoninDrug

    Melatonin for injection 1 mg/mL

  • Isotonic sodium chloride solutionDrug

    Sodium chloride 0.9 % for injection

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Incidence of emergence agitationTime frame: Up to approximately 4 hours corresponding to stay in Post-Anesthetic Care Unit (PACU).

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Department of Anesthesiology, Juliane Marie Center, Rigshospitalet

    Copenhagen, Capital Region, Denmark · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.